Evidence map›Paper›PMID 37509214›Full record

ArticleCancers2023

Machine Learning Integrating

Michail E Klontzas, Emmanouil Koltsakis, Georgios Kalarakis, Kiril Trpkov, Thomas Papathomas, Apostolos H Karantanas, Antonios Tzortzakakis

Open access · goldAbstract read
In one paragraph

Article in Cancers, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. SNMMI/EANM/ACNM Procedure Standard/Procedure Guideline on the Use of Molecular Imaging for Renal Mass Characterization.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Guideline
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

Michail E KlontzasDepartment of Medical Imaging, University Hospital of Heraklion, Heraklion 71110, Greece.ORCID 0000-0003-2731-933X
Emmanouil KoltsakisDepartment of Diagnostic Radiology, Karolinska University Hospital, Stockholm 17177, Sweden.ORCID 0000-0003-2964-315X
Georgios KalarakisDepartment of Diagnostic Radiology, Karolinska University Hospital, Stockholm 17177, Sweden.ORCID 0000-0002-5333-5993
Kiril TrpkovAlberta Precision Labs, Department of Pathology and Laboratory Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB T2L 2K5, Canada.
Thomas PapathomasInstitute of Metabolism and Systems Research, University of Birmingham, Birmingham B15 2TT, UK.
Apostolos H KarantanasDepartment of Medical Imaging, University Hospital of Heraklion, Heraklion 71110, Greece.
Antonios TzortzakakisDivision of Radiology, Department for Clinical Science, Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm 14152, Sweden.ORCID 0000-0001-7563-732X
Karolinska University Hospital · SEUniversity of Crete · GRUniversity of Calgary · CAVestre Viken Hospital Trust · NO

Funding

VINNOVA 2015-0180
6 · The paper itself

Abstract

The increasing evidence of oncocytic renal tumors positive in

Indexed as

99mTc Sestamibi SPECT/CTartificial intelligencemachine learningradiomicsrenal cell carcinomarenal oncocytic neoplasiarenal oncocytomaXGboost

Identifiers

PMID37509214
PMCPMC10377512
OpenAlexW4383820687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.